Navigation Links
Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference
Date:3/5/2012

RESEARCH TRIANGLE PARK, N.C., March 5, 2012 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that Kenneth I. Moch, President and Chief Executive Officer, will present at Cowen and Company's 32nd Annual Health Care Conference on Tuesday, March 6, 2012 at 3:00 pm ET at The Boston Marriott Copley Place in Boston, Massachusetts.

Mr. Moch's presentation will include an update on the company's clinical pipeline, which includes its lead development program, CMX001.  CMX001 is being tested in ongoing placebo-controlled clinical trials and in open-label treatment protocols for the prophylaxis, preemption and treatment of double-stranded DNA viruses (dsDNA) viruses, including herpesviruses and adenoviruses, and as a potential biodefense countermeasure in the event of a smallpox release. CMX001 recently announced results for Study 201, a Phase 2 double-blind, placebo-controlled trial which evaluated the safety, tolerability and ability of CMX001 to prevent or control cytomegalovirus (CMV) disease in 230 CMV-seropositive allogeneic stem cell transplant recipients. CMX001 had a statistically significant benefit versus placebo in preventing CMV viremia and/or CMV disease 13 weeks post-transplant. These data were presented during the "Best Abstracts Plenary Session" at the 2012 BMT Tandem Meetings on February 3rd in San Diego.

About Chimerix

Chimerix is developing novel antiviral therapeutics with the potential to transform patient care in multiple settings, including transplant, oncology, acute care and global health. Utilizing proprietary lipid conjugate technology, the company's two clinical stage compounds have demonstrated the potential for enhanced activity, bioavailability and safety compared to currently approved drugs.

The company's lead candidate, CMX001, is a Lipid-Antiviral-Conjugate that delivers high intracellular levels of the active antiviral agent cidofo
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
2. Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox
3. Chimerix to Present at Two Upcoming Investor Conferences
4. Chimerix CEO George Painter, Ph.D., to Speak on Improving Biodefense Product Discovery and Development Strategies at Institute of Medicine Workshop
5. Chimerix Initiates Phase 2 Study of CMX001 in Stem Cell Transplant Recipients Seropositive for Cytomegalovirus
6. Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
7. Chimerix to Present at 9th Annual BIO Investor Forum
8. Chimerix Reaffirms Its Commitment to CMX001 as a Medical Countermeasure for Smallpox and Broad-Spectrum Antiviral Agent
9. Chimerix to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
10. Chimerixs Antiviral CMX157 Demonstrates Positive Phase 1 Clinical Results With Favorable Pharmacokinetics, Safety and Tolerability
11. Chimerix Commences CMX001 Open-Label Clinical Study for the Treatment of Patients With Life-Threatening or Serious dsDNA Viral Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and NEW YORK and ... -- As the leading distributor of market intelligence, MarketResearch.com ... research report by IQ4I Research and Consultancy focusing on ... learn more about IQ4I Research visit: http://www.marketresearch.com/land/publisher.asp?vendorid=4023&progid=86891 ... Active Pharmaceutical Ingredients Global Market – Forecast to 2020 ...
(Date:11/26/2014)... CHARLOTTE, N.C. , Nov. 25, 2014  At ... San Antonio this October, KaVo Kerr Group ... Institute Technology Expo, offering attendees the opportunity to see ... to well-respected key opinion leaders deliver lectures on the ... Kerr Group products include the new DEXIS CariVu Caries ...
(Date:11/26/2014)... 2014 Reinforcing its commitment to enabling confident ... PHG AEX: PHIA) today announced 510(k) clearance ... its IQon Spectral CT , presenting an entirely ... adds a new dimension to Computed Tomography (CT) imaging, ... structures based on their material content within a single ...
Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3
... (Nasdaq: CEPH ) today announced that the ... U.S. Food and Drug Administration (FDA) for the supplemental ... for the treatment of patients with excessive sleepiness associated ... its letter to the company, the FDA reiterated its ...
... (Nasdaq: DRRX ) today reported that King Pharmaceuticals, ... (Nasdaq: PTIE ) have announced that King has ... U.S. Food and Drug Administration (FDA) in response to a ...  This is a Class 2 resubmission with a six month ...
Cached Medicine Technology:Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 2Cephalon Receives Complete Response Letter for NUVIGIL for the Treatment of Excessive Sleepiness Associated With Jet Lag Disorder 3REMOXY® New Drug Application Resubmitted 2REMOXY® New Drug Application Resubmitted 3
(Date:11/27/2014)... November 28, 2014 Recently, DressVe , ... 2014 Cyber Monday Sales, which are valid during Nov. 29 ... are available on these new dresses, up to 90% off. ... $69. Click to view more at http://www.dressve.com/ , ... really a great way to showcase somebody’s personality and figure. ...
(Date:11/27/2014)... 28, 2014 This is a professional ... global Bronchoscopes industry with a focus on the Chinese ... status of the Bronchoscopes manufacturers and is a valuable ... interested in the industry. , Firstly, the report provides ... applications and manufacturing technology. Then, the report explores the ...
(Date:11/27/2014)... November 28, 2014 The American Society for ... social media campaign in honor of World AIDS Day 2014. ... tested. Find a cure.” icon and infographic designed to generate ... getting tested for HIV. , ASCP has asked members to ... “Give a minute. Get Tested. Find a cure.” icon and ...
(Date:11/27/2014)... Vancouver, BC (PRWEB) November 27, 2014 ... http://www.idataresearch.com ), those companies looking to break into the ... in other medical specialties, other than the MIS field ... almost one-third of the U.S. surgical robotics market by ... nearing saturation,” explains Dr. Kamran Zamanian, CEO and President ...
(Date:11/27/2014)... 2014 In a world enveloped ... sleep has lessened, and due to the intrusion ... of sleep has eroded. According to Web MD, ... job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high ... an incalculable amount, leading not only to dissatisfied ...
Breaking Medicine News(10 mins):Health News:DressVe.com Introduces Its 2014 Special Monday Sales To The Global Customers 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 2Health News:Bronchoscopes Industry 2019 Forecasts for Global and China Region in New Research Report at ReportsnReports.com 3Health News:ASCP Launches Social Media Campaign in Honor of World AIDS Day 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... SMA, the leading ... toddler mortality, BETHESDA, Md., Sept. 28 With the ... Representatives and the U.S.,Senate to create a national clinical trials ... hosting a two-day,summit to work toward reducing or eliminating barriers ...
... proactive in diagnosing the condition, study says , , FRIDAY, Sept. ... depression before, during or after pregnancy, a new study finds. ... mother, her baby and her entire family, according to the ... Journal of Psychiatry . , "The prevalence of women diagnosed ...
... Bradley,Pharmaceuticals, Inc. (NYSE: BDY ) today announced ... gel 0.06%) at,the 18th Annual North American Menopause ... Texas from October 3-6, 2007. Elestrin(TM) is ... prescription, for the treatment of moderate-to-severe,vasomotor symptoms associated ...
... and,famous Chicago chefs watching their every move, the competition ... Battle of the Hospital,Chefs. Chef William Read, however, ... patients at Saint Mary,s Health Care in Grand Rapids, ... the reigning champion of,chefs among the nearly 550 Consorta ...
... (NSF) is a newly identified debilitating and painful condition ... by a thickening and hardening of the skin. It ... also affect internal organs and can progress so rapidly ... few weeks. Although it is not clear what causes ...
... family support and problems in ones neighborhood are associated ... to researchers in Vancouver, Canada. , Social environment has ... asthma manifestations in youth, but few studies have empirically ... levels and their implications for childhood asthma. , Edith ...
Cached Medicine News:Health News:15% of Women Struggle With Pregnancy-Related Depression 2Health News:15% of Women Struggle With Pregnancy-Related Depression 3Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 2Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 3Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 4Health News:Bradley Pharmaceuticals to Feature Elestrin(TM) at North American Menopause Society Annual Meeting 5Health News:National Battle of the Hospital Chefs Cooks Up a Winner 2Health News:Higher death rates in kidney patients with newly recognized disease 2Health News:Higher death rates in kidney patients with newly recognized disease 3Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 2Health News:Dysfunctional families and bad neighborhoods may worsen asthma in children and adolescents 3
One step Immuno-Chromatographic Assay for the detection of C. difficile toxin A....
... If the optical viewing aids should not ... Almost every household has a television set today. ... images can be enlarged up to 70 times. ... the reading material on the television monitor. The ...
... better resolution, accuracy and easy operation TOMEYs ... rings (same as TMS-1), providing high resolution. ... & repeatability. The small cone design eliminates ... corneal coverage. The low light level of ...
... Pachymeter SP-3000 covers all needs regarding pachymetry ... health care., ,Compact design, colored touch-screen and ... be an "easy-to-use unit.,The wide measurement range ... you the possibility to measure very thin ...
Medicine Products: